/ Print /

Pharmacy Best Practices

New diabetes medications help address linked diseasesExperts share updates on new diabetes medications, and provide an overview of what’s coming.
Poll: Few consumers trust health orgs, pharmaA new report has troubling findings for payers, providers, and technology companies. Here are the key takeaways, and reactions from experts.
Top 3 pharmacy challenges in 2017: Two-pronged solutionHere are three pharmacy challenges facing healthcare executives and a two-pronged solution to help solve them.
Top challenges in cancer careCancer drug costs remain the most critical challenge in care, among other things.
Watch list 2017: Top therapeutic areas
Watch list 2017: Top therapeutic areasFind out about the latest treatment and drug pipeline developments
Top pharmacy challenges of 2017
Top pharmacy challenges of 2017High drug prices continue to plague payers, but various contributing factors intensify the problem.
Will new autoimmune drugs address cost concerns?Find out what’s in the drug pipeline for autoimmune disease.
Top 2017 challenges healthcare executives face
Top 2017 challenges healthcare executives faceResults from Managed Healthcare Executive’s annual State of the Industry Survey reveal which issues will hit managed healthcare hardest in 2017.
Are payers optimistic about biosimilars’ savings?As more biosimilars are approved, plans and PBMs will continue to evolve their strategies regarding coverage and formulary management of these new medications.
Four innovative models rein in pharma costs
Four innovative models rein in pharma costsPlans and PBMs are finding new ways to rein in pharmacy costs.